Search
for
Sort by
Research 391–420 of 1000+
- Gut Microbiota and Autoimmune Alopecia Areata: Current Insights from the Literature
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- O potencial terapêutico da hidroxicloroquina no tratamento de alopecias autoimunes
- 606 The role of diet in patients with autoimmune blistering disease: A survey of the International Pemphigus and Pemphigoid Foundation
- Dermoscopic evaluation of therapeutic response to intralesional triamcinolone acetonide in the treatment of Alopecia areata
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Activation of the integrated stress response in human hair follicles
- THE COVID- 19 VACCINATION: AUTOIMMUNE PHENOMENON ALOPECIA AREATA
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Diagnostic dilemma: Multiple Autoimmune Syndrome versus incomplete Graham-Little-Piccardi-Lassueur Syndrome overlap mixed connective tissue disease
- DERMOSCOPIC EVALUATION OF THERAPEUTIC RESPONSE IN ALOPECIA AREATA
- Concurrent hepatitis B and autoimmune hepatitis a rare presentation of acute liver failure: a case report
- Management of autoimmune associated alopecia areata
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Immunosuppressive therapy in autoimmune disease — A review
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Clinical evaluation and treatment response in Patients with non-scarring alopecia: A Prospective Study of 200 Cases
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis